Sertoli MR - Search Results

1

Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.

Pronzato P, Campora E, Amoroso D, Bertelli G, Botto F, Conte PF, Sertoli MR, Rosso R. Pronzato P, et al. Among authors: sertoli mr. Am J Clin Oncol. 1989 Dec;12(6):481-5. doi: 10.1097/00000421-198912000-00004. Am J Clin Oncol. 1989. PMID: 2589228

2

Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.

Campora E, Pronzato P, Amoroso D, Bertelli GF, Venturini M, Baldini E, Brunetti I, Sertoli MR, Conte P, Rosso R. Campora E, et al. Among authors: sertoli mr. Anticancer Res. 1992 Sep-Oct;12(5):1555-8. Anticancer Res. 1992. PMID: 1444221

3

Continuous venous infusion of vinblastine in metastatic breast cancer.

Pronzato P, Queirolo P, Vidili MG, Amoroso D, Bertelli G, Sertoli MR, Rosso R. Pronzato P, et al. Among authors: sertoli mr. Chemotherapy. 1991;37(2):146-9. doi: 10.1159/000238847. Chemotherapy. 1991. PMID: 2032471 Clinical Trial.

4

Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.

Campora E, Baldini E, Rubagotti A, Chiara S, Bruzzi P, Sertoli MR, Rosso R. Campora E, et al. Among authors: sertoli mr. J Chemother. 1990 Oct;2(5):336-9. doi: 10.1080/1120009x.1990.11739039. J Chemother. 1990. PMID: 2090773 Clinical Trial.

5

Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.

Pronzato P, Amoroso D, Bertelli G, Queirolo P, Sertoli MR, Rosso R. Pronzato P, et al. Among authors: sertoli mr. Anticancer Res. 1990 Nov-Dec;10(6):1743-5. Anticancer Res. 1990. PMID: 2126683

6

Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.

Merlano M, Rosso R, Sertoli MR, Bonelli L, Margarino G, Grimaldi A, Benasso M, Gardin G, Corvó R, Scarpati D, et al. Merlano M, et al. Among authors: sertoli mr. J Clin Oncol. 1988 Apr;6(4):627-32. doi: 10.1200/JCO.1988.6.4.627. J Clin Oncol. 1988. PMID: 2451713 Clinical Trial.

7

Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.

Rosso R, Boccardo F, Brema F, Sertoli MR, Amoroso D, Bertelli G, Pronzato P. Rosso R, et al. Among authors: sertoli mr. Anticancer Res. 1989 Jul-Aug;9(4):1153-6. Anticancer Res. 1989. PMID: 2817796

8

Randomized cooperative study of perioperative chemotherapy in breast cancer.

Sertoli MR, Bruzzi P, Pronzato P, Queirolo P, Amoroso D, Del Mastro L, Venturini M, Vigani A, Bertelli G, Campora E, et al. Sertoli MR, et al. J Clin Oncol. 1995 Nov;13(11):2712-21. doi: 10.1200/JCO.1995.13.11.2712. J Clin Oncol. 1995. PMID: 7595729 Clinical Trial.

9

Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.

Pronzato P, Rubagotti A, Amoroso D, Bertelli G, Queirolo P, Sertoli MR, Rosso M, Gallotti P, Monzeglio C, Rosso R. Pronzato P, et al. Among authors: sertoli mr. Am J Clin Oncol. 1993 Dec;16(6):522-5. doi: 10.1097/00000421-199312000-00013. Am J Clin Oncol. 1993. PMID: 8256770 Clinical Trial.

10

Impact of irradiation of residual breast on adjuvant chemotherapy dose intensity.

Pronzato P, Miglietta L, Rubagotti A, Bertelli G, Queirolo P, Guenzi M, Sertoli MR, Vitale V, Rosso R. Pronzato P, et al. Among authors: sertoli mr. Am J Clin Oncol. 1993 Feb;16(1):58-60. doi: 10.1097/00000421-199302000-00015. Am J Clin Oncol. 1993. PMID: 8424406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters